- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.76 Å
- Oligo State
- hetero-1-1-mer
- Ligands
- 1 x GLY- GLY- ALA- ILE- SER: 5-mer lipopeptide from Protein Nef(Non-covalent)
- 3 x ZN: ZINC ION(Non-covalent)
ZN.2: 2 residues within 4Å:- Chain A: H.193
- Chain B: D.99
2 PLIP interactions:1 interactions with chain A, 1 interactions with chain B- Metal complexes: A:H.193, B:D.99
ZN.3: 4 residues within 4Å:- Chain A: A.1, H.4
- Ligands: EDO.10, EDO.12
3 PLIP interactions:2 interactions with chain A, 1 Ligand-Water interactions- Metal complexes: A:A.1, A:H.4, H2O.1
ZN.16: 2 residues within 4Å:- Chain B: H.52
- Ligands: EDO.21
2 PLIP interactions:1 interactions with chain B, 1 Ligand-Water interactions- Metal complexes: B:H.52, H2O.7
- 16 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
EDO.4: 7 residues within 4Å:- Chain A: M.6, Y.8, Q.64, Y.160, E.164, S.168, Y.172
Ligand excluded by PLIPEDO.5: 7 residues within 4Å:- Chain A: D.123, Y.124, I.125, A.126, T.135, A.136, A.137
Ligand excluded by PLIPEDO.6: 5 residues within 4Å:- Chain A: F.9, Y.28, D.30, D.31
- Chain B: Y.64
Ligand excluded by PLIPEDO.7: 2 residues within 4Å:- Chain A: D.138, E.139
Ligand excluded by PLIPEDO.8: 5 residues within 4Å:- Chain A: T.179, R.182, E.184, Y.210, G.240
Ligand excluded by PLIPEDO.9: 7 residues within 4Å:- Chain A: G.208, D.239, T.241, F.242, Q.243
- Chain B: R.13, H.14
Ligand excluded by PLIPEDO.10: 9 residues within 4Å:- Chain A: A.1, H.4, D.30, L.180, R.182, A.183, P.211, E.265
- Ligands: ZN.3
Ligand excluded by PLIPEDO.11: 5 residues within 4Å:- Chain A: E.213, T.215, Q.263, H.264, E.265
Ligand excluded by PLIPEDO.12: 4 residues within 4Å:- Chain A: A.1, H.4, Q.181
- Ligands: ZN.3
Ligand excluded by PLIPEDO.13: 7 residues within 4Å:- Chain A: Y.86, Y.119, R.122, D.123, Y.124, D.138
- Ligands: EDO.14
Ligand excluded by PLIPEDO.14: 5 residues within 4Å:- Chain A: Y.86, Q.88, Y.119, D.120
- Ligands: EDO.13
Ligand excluded by PLIPEDO.17: 6 residues within 4Å:- Chain A: F.9, M.99
- Chain B: F.57, S.58, K.59, W.61
Ligand excluded by PLIPEDO.18: 4 residues within 4Å:- Chain A: R.22
- Chain B: S.34, D.35, L.55
Ligand excluded by PLIPEDO.19: 10 residues within 4Å:- Chain A: W.205, L.207, R.235, Q.243
- Chain B: Y.11, S.12, R.13, H.14, P.15, M.100
Ligand excluded by PLIPEDO.20: 5 residues within 4Å:- Chain B: E.37, D.39, R.82, N.84, P.91
Ligand excluded by PLIPEDO.21: 2 residues within 4Å:- Chain B: H.52
- Ligands: ZN.16
Ligand excluded by PLIP- 1 x CL: CHLORIDE ION(Non-functional Binders)
- 1 x MYR: MYRISTIC ACID(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Morita, D. et al., Crystal structure of the N-myristoylated lipopeptide-bound MHC class I complex. Nat Commun (2016)
- Release Date
- 2016-01-13
- Peptides
- Major histocompatibility complex class I: A
Beta-2-microglobulin: B - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
GB
H
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.76 Å
- Oligo State
- hetero-1-1-mer
- Ligands
- 1 x GLY- GLY- ALA- ILE- SER: 5-mer lipopeptide from Protein Nef(Non-covalent)
- 3 x ZN: ZINC ION(Non-covalent)
- 16 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
- 1 x CL: CHLORIDE ION(Non-functional Binders)
- 1 x MYR: MYRISTIC ACID(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Morita, D. et al., Crystal structure of the N-myristoylated lipopeptide-bound MHC class I complex. Nat Commun (2016)
- Release Date
- 2016-01-13
- Peptides
- Major histocompatibility complex class I: A
Beta-2-microglobulin: B - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
GB
H